Last week, we outlined how the recent recovery in leverage in the derivative markets combined with thin end-of-year liquidity would exacerbate volatility. This same message continues...
The market had been a mess for most of 2021. But even as the weakness persisted at the end of the year, we repeatedly highlighted the strength coming through in the IT space.
Well, this post is no different. We have breakouts, people! Let's...
From the desk of Steven Strazza @Sstrazza and Ian Culley @Ianculley
In recent weeks, we’ve been diving into individual commodity groups to size up the structural trend and to get a better idea of where we’re likely headed in the new year...
Here is a list of trade ideas organized by date, ticker symbol and directional bias. Please make sure you have clicked on the link and read the details surrounding the trade before acting upon any of them. Also, make sure you have checked with your...
We’re buying an $MPC Feb/Apr 70 Call Calendar Spread for around a $1.10 debit. This means we’ll be short the February 70 calls and long an equal amount of April 70 calls for a net debit
Check out our short video with the thought process behind...
From the desk of Steve Strazza @Sstrazza and Ian Culley @Ianculley
With the exception of US large-caps, the market remains range-bound for most risk assets. At the same time, most defensive assets are failing to catch any meaningful bid...
I'll spare you the suspense -- we're getting long Marathon Petroleum $MPC here.
The title of today's post is not a trite pun. We are indeed positioning for a bullish move, but it may take a little bit to develop the way we want it to.
We've been talking about how the major strength in the current market has been coming through in IT. But what we also noticed is that while Nifty Pharma wasn't looking pretty on an absolute basis, the relative strength is pointing in a different...
